SYMPHONY consortium: Orchestrating personalized treatment for patients with bleeding disorders.
Marjon H CnossenIris van MoortSimone H ReitsmaMoniek P M de MaatRoger E G SchutgensRolf T UrbanusHester Floor LingsmaRon A A MathotSamantha C GouwKarina MeijerAnnelien L BredenoordRieke van der GraafKarin FijnvandraatAlexander Benjamin MeijerEmile van den AkkerRuben BieringsJeroen C J EikenboomMaartje van den BiggelaarMasja De HaasJan VoorbergFrank W G Leebeeknull nullPublished in: Journal of thrombosis and haemostasis : JTH (2022)
SYMPHONY will perform research on all aspects of care, treatment individualization in patients with inborn bleeding disorders as well as diagnostic innovations and results of molecular genetics and cellular model technology with regard to the hemostatic process. We believe that these research investments will lead to health care innovations with long-term clinical and societal impact. This consortium has been made possible by a governmental, competitive grant from the Netherlands Organization for Scientific Research (NWO) within the framework of the NWA-ORC Call grant agreement NWA.1160.18.038.